CSPC Pharmaceutical initiates Phase Ib trial of JMT206 injection in China
CSPC Pharmaceutical Group Limited started a Phase Ib study in China to evaluate JMT206 for weight management in adult patients, as monotherapy or with semaglutide.
CSPC Pharmaceutical Group Limited started a Phase Ib study in China to evaluate JMT206 for weight management in adult patients, as monotherapy or with semaglutide.